This clinical trial aims to determine whether navigational bronchoscopic or CT-guided marking is more effective for localizing small pulmonary nodules in minimally invasive thoracic surgery. It will also assess the safety of both methods. The main questions to answer are: * Which of the two methods enables the surgeon to locate the lesion more quickly during surgery? * Does using the newer navigational bronchoscopic method reduce the number of insufficient resections, meaning that the lesions were not completely removed, thus affecting the surgical margin? Researchers will compare navigational bronchoscopic ICG (visible green dye on the screen) marking to CT-guided transthoracic radioisotope targeting (a substance that emits radiation and can be detected with a specific device) to evaluate whether bronchoscopy with ICG dye is equally effective or even superior without exposing patients to radiation. Participants will: * Undergo an additional procedure before surgery to make the lesions detectable (Preoperative marking). * Proceed to surgery in accordance with standard practices. * Visit the clinic once after three weeks for follow-up checks and tests. * Grant access to the pathological results for researchers to analyze and store data.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time of Surgery
Timeframe: From the initiation of anesthesia to the completion of the surgery
Surgical Satisfaction Survey
Timeframe: From the completion of surgery within 24 hours